Igs85em2Pero
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Igs85em2Pero |
| Name: |
intergenic site 85; endonuclease-mediated mutation 2, Pedro P Rocha |
| MGI ID: |
MGI:7718688 |
| Synonyms: |
CTCFi3x+ |
| Gene: |
Igs85 Location: Chr3:34778989-34778990 bp Genetic Position: Chr3, Syntenic
|
| Alliance: |
Igs85em2Pero page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Modified regulatory region) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: The following 321 bp concatenation of three CTCF-binding-motif-containing sequences (in this order) was inserted between GRCm39:chr3:34778989 and 34778990 using an sgRNA (equivalent to CCTGTGCTGTACCTAATAGTAGC) and an ssODN template using CRISPR/Cas9 technology: reverse complement of GRCm39:chr8:13511990-13512089, chr1:34257543-34257652 and reverse complement of chr4:132978080-132978190. This allele was created using zygotes that contain the Igs84em1Pero allele, where the same sequence was inserted in the opposite orientation upstream of this allele.
(J:342647)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Igs85 Mutation: |
0 strains or lines available
|
|
| Original: |
J:342647 Chakraborty S, et al., Enhancer-promoter interactions can bypass CTCF-mediated boundaries and contribute to phenotypic robustness. Nat Genet. 2023 Feb;55(2):280-290 |
| All: |
1 reference(s) |
|